Glioblastoma
Data on glioblastoma reported by M.M. Zulkifli and co-researchers
Published in Vaccine Weekly, April 22nd, 2009
"Newcastle disease virus ( NDV) is a virus of paramyxovirus family and lately has been studied for the treatment of cancer in human. In this study, we successfully determined the oncolysis potential of NDV vaccine, V4UPM tested on the human glioblastoma multiform cell line (DBTRG.05MG) and human glioblastoma astrocytoma cell line (U-87MG) in vitro and in vivo," scientists writing in the journal Neurological Research report.
"The V4UPM strain is a modified V4 strain developed as thermostable feed pellet vaccine for poultry. The objectives of this study were mainly to evaluate the cytolytic effect and subsequently determine the brain tumor regression potential...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-04-22)
More Articles from Vaccine Weekly
- Allergies
New allergies data have been reported by researchers at Medical University of Vienna - Anthrax
Research from Y.P. Gauthier and co-authors in the area of anthrax published - Bacillus Calmette-Guerin Vaccines
Research in the area of Bacillus calmette-guerin vaccines reported from University of Texas - Blood Safety
New blood safety study findings recently were published by H.E. Mei and co-researchers - Campylobacter
Research on campylobacter detailed by M.A. Monteiro and co-authors - Clinical Trial Research
Researchers from University of Washington report details of new studies and findings in the area of clinical trial research - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
